Argomenti trattati
As the role of pharmacists evolves, specialized training in nicotine replacement therapy (NRT) is increasingly essential. This online course is specifically designed to fulfill the two-hour training requirement mandated for pharmacists to begin providing NRT. Participants will gain valuable insights into the protocols outlined in Section 1746.2 of the California Code of Regulations, ensuring they are well-equipped to assist patients seeking to quit smoking.
This educational opportunity addresses a variety of crucial topics, including an overview of FDA-approved first-line medications for smoking cessation. Pharmacists will learn to identify patients who may benefit from therapy and how to provide effective counseling by leveraging available resources.
Course objectives and learning outcomes
Upon successful completion of this course, pharmacists will be able to:
- Understand the protocols for furnishing NRT in accordance with regulatory guidelines.
- Identify suitable candidates for nicotine replacement therapy.
- Effectively counsel patients on cessation options and available resources.
This course goes beyond compliance; it empowers pharmacists to play a critical role in public health by assisting individuals in their journey to quit smoking.
Accreditation and continuing education credits
The California Pharmacists Association (CPhA) is accredited by the Accreditation Council for Pharmacy Education (ACPE), serving as a recognized provider of continuing pharmacy education. Participants who complete the course and submit an evaluation will receive 2 hours (0.2 CEUs) of Continuing Pharmacy Education Credit. To access their statement of credit, pharmacists can log into the CPE Monitor website using their unique credentials. It is important to note that processing for CPE credits may take up to four weeks.
Registration is straightforward. Once registered, participants will receive a confirmation email with instructions on how to access the on-demand course. However, it is essential to understand that cancellations or refunds cannot be issued after login information is sent. Therefore, prospective participants should thoroughly review the course content before finalizing their registration to ensure it aligns with their educational needs.
Instructor expertise
The course features esteemed instructors with extensive backgrounds in pharmacy practice and tobacco cessation research. Lisa Kroon, PharmD, CDE, FAPhA, serves as a Professor and Chair of Clinical Pharmacy at the University of California, San Francisco. With her experience in managing diabetes and chronic illnesses, she brings a wealth of knowledge to the course.
Robin Corelli, PharmD, also a professor at the same institution, has dedicated nearly two decades to tobacco cessation efforts. Her experience in training various healthcare providers enhances the course’s relevance and practical application.
Additionally, Karen Hudmon, DrPH, MS, RPh, a Professor of Pharmacy Practice at Purdue University College of Pharmacy, contributes her expertise in cancer prevention and patient behavior research, having trained thousands of health professionals worldwide in tobacco cessation.
Target audience and course availability
This course is tailored for pharmacists across all practice settings, ensuring they are prepared to address smoking cessation effectively. The course was released on June 3, 2025, and is available for completion at the participant’s convenience within 30 days of registration.
This educational opportunity addresses a variety of crucial topics, including an overview of FDA-approved first-line medications for smoking cessation. Pharmacists will learn to identify patients who may benefit from therapy and how to provide effective counseling by leveraging available resources.0